SG10201912866RA - Broad-spectrum anti-infective peptides - Google Patents
Broad-spectrum anti-infective peptidesInfo
- Publication number
- SG10201912866RA SG10201912866RA SG10201912866RA SG10201912866RA SG10201912866RA SG 10201912866R A SG10201912866R A SG 10201912866RA SG 10201912866R A SG10201912866R A SG 10201912866RA SG 10201912866R A SG10201912866R A SG 10201912866RA SG 10201912866R A SG10201912866R A SG 10201912866RA
- Authority
- SG
- Singapore
- Prior art keywords
- broad
- spectrum anti
- infective peptides
- infective
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
- C07K14/1816—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus), border disease virus
- C07K14/1833—Hepatitis C; Hepatitis NANB
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D189/00—Coating compositions based on proteins; Coating compositions based on derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Dermatology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Pulmonology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Materials Engineering (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562184354P | 2015-06-25 | 2015-06-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201912866RA true SG10201912866RA (en) | 2020-02-27 |
Family
ID=57586064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201912866RA SG10201912866RA (en) | 2015-06-25 | 2016-06-24 | Broad-spectrum anti-infective peptides |
Country Status (12)
Country | Link |
---|---|
US (3) | US10351604B2 (de) |
EP (1) | EP3313862B9 (de) |
JP (2) | JP6768012B2 (de) |
KR (1) | KR20180037185A (de) |
CN (1) | CN107922461A (de) |
AU (1) | AU2016281477A1 (de) |
BR (1) | BR112017028190A2 (de) |
CA (1) | CA2989399A1 (de) |
HK (1) | HK1248248A1 (de) |
MX (1) | MX2017016227A (de) |
SG (1) | SG10201912866RA (de) |
WO (1) | WO2016209173A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10351604B2 (en) | 2015-06-25 | 2019-07-16 | Nanyang Technological University | Broad-spectrum anti-infective peptides |
ES2980222T3 (es) | 2018-08-30 | 2024-09-30 | Osel Inc | Bacteriocinas para mejorar la colonización vaginal de Lactobacillus productor de peróxido de hidrógeno para la salud de reproducción femenina |
US20230256049A1 (en) * | 2020-07-24 | 2023-08-17 | Oak Crest Institute Of Science | Materials and methods for the prevention and treatment of viral respiratory diseases |
WO2022220749A1 (en) * | 2021-04-13 | 2022-10-20 | Nanyang Technological University | Anti-viral peptide compositions and methods to improve biological activity thereof |
EP4308146A1 (de) * | 2021-04-27 | 2024-01-24 | Oak Crest Institute of Science | Materialien und verfahren zur prävention und behandlung von viruserkrankungen |
CN117756904B (zh) * | 2023-12-22 | 2024-05-24 | 潍坊医学院 | 一种订书肽及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7326536B2 (en) | 2001-05-03 | 2008-02-05 | Eli Lilly And Company | Agents for treatment of HCV and methods of use |
EP1357127A1 (de) * | 2002-04-10 | 2003-10-29 | Immusystems GmbH | CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope |
US7378234B2 (en) * | 2002-09-13 | 2008-05-27 | Intercell Ag | Method for isolating hepatitis C virus peptides |
US7989425B2 (en) * | 2002-09-27 | 2011-08-02 | Genexine Inc. | Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirus |
US20060088819A1 (en) * | 2004-05-17 | 2006-04-27 | Chiron Corporation | Truncated hepatitis C virus NS5 domain and fusion proteins comprising same |
JP2009510122A (ja) | 2005-09-29 | 2009-03-12 | ザ スクリプス リサーチ インスティテュート | ウイルスペプチドおよびフラビウイルス科のウイルスに対してウイルス感染を阻害するためのその使用 |
WO2008133759A2 (en) | 2007-01-10 | 2008-11-06 | The Scripps Research Institute | Antiviral peptides |
KR101623985B1 (ko) * | 2007-03-28 | 2016-05-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 스티칭된 폴리펩티드 |
WO2009014615A2 (en) | 2007-07-19 | 2009-01-29 | The Board Of Trustees Of The Leland Stanford Junior University | Amphipathic alpha-helical peptide compositions as antiviral agents |
JP2011508785A (ja) | 2008-01-03 | 2011-03-17 | マサチューセッツ インスティテュート オブ テクノロジー | デコイインフルエンザ処置 |
US8586707B2 (en) | 2008-09-16 | 2013-11-19 | The Research Foundation Of State University Of New York | Stapled peptides and method of synthesis |
RU2447899C2 (ru) | 2010-05-27 | 2012-04-20 | Михаил Валентинович Филатов | Композиция для лечения гепатита с и способ лечения гепатита с |
US9309236B2 (en) * | 2011-10-05 | 2016-04-12 | The Board Of Trustees Of The Leland Stanford Junior University | PI-kinase inhibitors with broad spectrum anti-infective activity |
US10351604B2 (en) | 2015-06-25 | 2019-07-16 | Nanyang Technological University | Broad-spectrum anti-infective peptides |
-
2016
- 2016-06-24 US US15/738,730 patent/US10351604B2/en active Active
- 2016-06-24 MX MX2017016227A patent/MX2017016227A/es unknown
- 2016-06-24 AU AU2016281477A patent/AU2016281477A1/en not_active Abandoned
- 2016-06-24 EP EP16814828.6A patent/EP3313862B9/de active Active
- 2016-06-24 WO PCT/SG2016/050291 patent/WO2016209173A1/en active Application Filing
- 2016-06-24 SG SG10201912866RA patent/SG10201912866RA/en unknown
- 2016-06-24 BR BR112017028190A patent/BR112017028190A2/pt not_active IP Right Cessation
- 2016-06-24 CA CA2989399A patent/CA2989399A1/en not_active Abandoned
- 2016-06-24 CN CN201680049114.2A patent/CN107922461A/zh active Pending
- 2016-06-24 KR KR1020187002411A patent/KR20180037185A/ko unknown
- 2016-06-24 JP JP2017567056A patent/JP6768012B2/ja active Active
-
2018
- 2018-06-13 HK HK18107687.3A patent/HK1248248A1/zh unknown
-
2019
- 2019-05-23 US US16/421,119 patent/US20200087349A1/en not_active Abandoned
- 2019-10-07 JP JP2019184326A patent/JP2020040950A/ja active Pending
-
2021
- 2021-06-15 US US17/348,593 patent/US11866460B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3313862B1 (de) | 2023-06-07 |
EP3313862A1 (de) | 2018-05-02 |
EP3313862B9 (de) | 2023-10-04 |
WO2016209173A1 (en) | 2016-12-29 |
US11866460B2 (en) | 2024-01-09 |
JP6768012B2 (ja) | 2020-10-14 |
US10351604B2 (en) | 2019-07-16 |
US20180186837A1 (en) | 2018-07-05 |
JP2020040950A (ja) | 2020-03-19 |
US20220402972A1 (en) | 2022-12-22 |
AU2016281477A1 (en) | 2018-01-04 |
KR20180037185A (ko) | 2018-04-11 |
JP2018531880A (ja) | 2018-11-01 |
US20200087349A1 (en) | 2020-03-19 |
CN107922461A (zh) | 2018-04-17 |
MX2017016227A (es) | 2019-03-28 |
HK1248248A1 (zh) | 2018-10-12 |
EP3313862A4 (de) | 2019-01-23 |
BR112017028190A2 (pt) | 2018-09-04 |
CA2989399A1 (en) | 2016-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201520559D0 (en) | Peptides | |
HK1248248A1 (zh) | 廣譜抗感染肽 | |
GB201520575D0 (en) | Peptides | |
GB201520536D0 (en) | Peptides | |
GB201520546D0 (en) | Peptides | |
GB201520545D0 (en) | Peptides | |
GB201520579D0 (en) | Peptides | |
GB201520563D0 (en) | Peptides | |
GB201520567D0 (en) | Peptides | |
GB201520550D0 (en) | Peptides | |
GB201520541D0 (en) | Peptides | |
GB201520539D0 (en) | Peptides | |
GB201520543D0 (en) | Peptides | |
GB201520544D0 (en) | Peptides | |
GB201520566D0 (en) | Peptides | |
GB201520562D0 (en) | Peptides | |
GB201520568D0 (en) | Peptides | |
GB201520557D0 (en) | Peptides | |
GB201520570D0 (en) | Peptides | |
GB201520542D0 (en) | Peptides | |
GB201520564D0 (en) | Peptides | |
GB201520548D0 (en) | Peptides | |
GB201520558D0 (en) | Peptides | |
GB201520534D0 (en) | Peptides | |
GB201520551D0 (en) | Peptides |